Literature DB >> 12546935

Substrate SARs in human P450s.

David F V Lewis1, Maurice Dickins.   

Abstract

Drug metabolism is now an integral part of the drug discovery process, and the cytochromes P450 (CYPs) are the most important family of enzymes involved in human drug metabolism. An increased understanding of the properties of the substrates for the major human CYPs is thus highly desirable. This article shows how key characteristics of CYP substrates, such as lipophilicity, molecular mass and hydrogen-bonding potential, govern selectivity towards individual CYPs. Importantly, the variation in binding affinities of 60 human CYP substrates can be explained by understanding the key physicochemical, structural and electronic characteristics that govern substrate binding to each isozyme.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12546935     DOI: 10.1016/s1359-6446(02)02412-1

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  10 in total

1.  Empirical regioselectivity models for human cytochromes P450 3A4, 2D6, and 2C9.

Authors:  Robert P Sheridan; Kenneth R Korzekwa; Rhonda A Torres; Matthew J Walker
Journal:  J Med Chem       Date:  2007-06-19       Impact factor: 7.446

Review 2.  Drug Metabolism in Preclinical Drug Development: A Survey of the Discovery Process, Toxicology, and Computational Tools.

Authors:  Naiem T Issa; Henri Wathieu; Abiola Ojo; Stephen W Byers; Sivanesan Dakshanamurthy
Journal:  Curr Drug Metab       Date:  2017       Impact factor: 3.731

3.  Effective virtual screening protocol for CYP2C9 ligands using a screening site constructed from flurbiprofen and S-warfarin pockets.

Authors:  Tímea Polgár; Dóra K Menyhárd; György M Keseru
Journal:  J Comput Aided Mol Des       Date:  2007-10-25       Impact factor: 3.686

4.  Low potency toxins reveal dense interaction networks in metabolism.

Authors:  William Bains
Journal:  BMC Syst Biol       Date:  2016-02-20

5.  Functioning of drug-metabolizing microsomal cytochrome P450s: In silico probing of proteins suggests that the distal heme 'active site' pocket plays a relatively 'passive role' in some enzyme-substrate interactions.

Authors:  Avanthika Venkatachalam; Abhinav Parashar; Kelath Murali Manoj
Journal:  In Silico Pharmacol       Date:  2016-02-19

Review 6.  Review of Ligand Specificity Factors for CYP1A Subfamily Enzymes from Molecular Modeling Studies Reported to-Date.

Authors:  Jayalakshmi Sridhar; Navneet Goyal; Jiawang Liu; Maryam Foroozesh
Journal:  Molecules       Date:  2017-07-08       Impact factor: 4.411

Review 7.  Descriptors of Cytochrome Inhibitors and Useful Machine Learning Based Methods for the Design of Safer Drugs.

Authors:  Tyler C Beck; Kyle R Beck; Jordan Morningstar; Menny M Benjamin; Russell A Norris
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-17

Review 8.  Insights on cytochrome p450 enzymes and inhibitors obtained through QSAR studies.

Authors:  Jayalakshmi Sridhar; Jiawang Liu; Maryam Foroozesh; Cheryl L Klein Stevens
Journal:  Molecules       Date:  2012-08-03       Impact factor: 4.411

9.  Characterization of CYPs and UGTs Involved in Human Liver Microsomal Metabolism of Osthenol.

Authors:  Pil Joung Cho; Sanjita Paudel; Doohyun Lee; Yun Ji Jin; GeunHyung Jo; Tae Cheon Jeong; Sangkyu Lee; Taeho Lee
Journal:  Pharmaceutics       Date:  2018-08-30       Impact factor: 6.321

Review 10.  Capter 11 Filtering in Drug Discovery.

Authors:  Christopher A Lipinski
Journal:  Annu Rep Comput Chem       Date:  2005-10-05
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.